Taiyen Biotech Co. Ltd.(TW:1737)
NT$29.900.00 (-0.17%)
TW:1737
Taiyen Biotech Co. Ltd. financials statements
NT$29.90
At close:0.00 (-0.17%)
Taiyen Biotech Co. Ltd. (1737) Financial Statements
Taiyen Biotech Co. Ltd. Financial Overview
Taiyen Biotech Co. Ltd.'s market cap is currently NT$5.98B. The company's EPS TTM is NT$1.95; its P/E ratio is 15.33; and it has a dividend yield of 4.68%. Taiyen Biotech Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 3.31B | NT$ 3.24B | NT$ 3.41B | NT$ 3.61B | NT$ 4.10B |
| Gross Profit | NT$ 1.34B | NT$ 1.32B | NT$ 1.21B | NT$ 1.28B | NT$ 1.37B |
| Operating Income | NT$ 476.14M | NT$ 430.81M | NT$ 312.66M | NT$ 535.11M | NT$ 515.86M |
| EBITDA | NT$ 720.11M | NT$ 657.96M | NT$ 530.52M | NT$ 640.00M | NT$ 718.84M |
| Net Income | NT$ 399.87M | NT$ 371.52M | NT$ 300.39M | NT$ 426.70M | NT$ 393.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 1.75B | NT$ 1.94B | NT$ 1.84B | NT$ 1.89B | NT$ 2.08B |
| Total Assets | NT$ 8.26B | NT$ 8.38B | NT$ 8.32B | NT$ 8.21B | NT$ 8.47B |
| Total Debt | NT$ 223.20M | NT$ 311.54M | NT$ 317.19M | NT$ 268.36M | NT$ 506.55M |
| Net Debt | NT$ -1.13B | NT$ -1.24B | NT$ -1.13B | NT$ -1.26B | NT$ -1.22B |
| Total Liabilities | NT$ 1.45B | NT$ 1.71B | NT$ 1.77B | NT$ 1.55B | NT$ 1.95B |
| Stockholders' Equity | NT$ 6.81B | NT$ 6.66B | NT$ 6.49B | NT$ 6.52B | NT$ 6.36B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 173.60M | NT$ 352.51M | NT$ 109.41M | NT$ 334.09M | NT$ 209.26M |
| Operating Cash Flow | NT$ 473.77M | NT$ 660.12M | NT$ 454.54M | NT$ 580.69M | NT$ 600.08M |
| Investing Cash Flow | NT$ -310.03M | NT$ -287.76M | NT$ -339.30M | NT$ -229.63M | NT$ -351.38M |
| Financing Cash Flow | NT$ -365.91M | NT$ -266.52M | NT$ -199.22M | NT$ -547.98M | NT$ -28.44M |
Currency in TWD
